Endothelin-1, but not endothelin-3, suppresses lipoprotein lipase gene expression in brown adipocytes differentiated in culture.
The effect of endothelins on lipoprotein lipase activity and lipoprotein lipase mRNA levels was studied in brown adipocytes differentiated in culture. Lipoprotein lipase activity was determined in two fractions; lipoprotein lipase released by heparin (10 IU/ml, 1 h) into the medium (heparin-releasable fraction) and lipoprotein lipase activity remaining in cells (extractable fraction). Time-course studies showed that endothelin 1 (10(-7) M) progressively decreased both lipoprotein lipase fractions (heparin-releasable, extractable), until nadir at 24 h. Endothelin-1 reduced both lipoprotein lipase activities (heparin-releasable, extractable) in a concentration-dependent manner, whereas endothelin-3 did not produce any significant changes in either of them. Northern blot analysis revealed that endothelin-1 (10(-7)-10(-11) M) caused a concentration-dependent decrease in lipoprotein lipase mRNA obtained from cells on day 9. Furthermore, pretreatment of brown adipocytes with endothelin ETA receptor antagonist FR139317 antagonized the endothelin-1-induced reduction of lipoprotein lipase activity and lipoprotein lipase mRNA. These results suggest that endothelin-1 decreases lipoprotein lipase activity by inhibiting the lipoprotein lipase gene expression in brown adipocytes differentiated in culture, possibly through endothelin ETA receptors on cell membranes. Because of marked reduction of lipoprotein lipase activity and its mRNA as a marker of adipogenic differentiation, endothelin-1 may have an inhibitory role in the differentiation of brown adipocytes.
Department of Pharmacology, Tokyo Women's Medical College, Japan.
Y
Y
Uchida
K
K
Irie
F
F
Tsukahara
K
K
Ohba
A
A
Ogawa
E
E
Fujii
T
T
Muraki
D017667:Adipocytes / Q000187:drug effects / Q000201:enzymology*; D002001:Adipose Tissue, Brown / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D000818:Animals; D001381:Azepines / Q000494:pharmacology; D015152:Blotting, Northern; D002454:Cell Differentiation; D002478:Cells, Cultured; D016232:Endothelins / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D007211:Indoles / Q000494:pharmacology; D008071:Lipoprotein Lipase / Q000096:biosynthesis* / Q000235:genetics; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000302:isolation & purification / Q000378:metabolism
D001381:Azepines; D016232:Endothelins; D007211:Indoles; D011506:Proteins; C079574:FR 139317; D012313:RNA; D008071:Lipoprotein Lipase